Puerto Rico’s pharma industry can be competitive with the rest of the world – unique advantages make it the perfect place for manufacturing

Puerto Rico has the legacy of being one of the most productive pharmaceutical manufacturing hubs in the world, let alone in the United States. Puerto Rico is a unique place that competes with both U.S. and global economies. Domestically, Puerto Rico leads all states in pharmaceutical production, more than doubling the next states of Indiana, California, and North Carolina. Internationally, Puerto Rico is also recognized as one of the key pharma destinations, along with Ireland, Singapore, and Switzerland. In fact, local engineers helped develop the capacities in other hubs around the world. Here are some of the strengths Puerto Rico offers: • 60-year experience in biopharmaceutical manufacturing and ancillary biomedical services • Logistics expertise in handling and shipping time- and temperature- sensitive materials • Favorable regulatory environment governed by the FDA • Regional leadership in biopharmaceutical production with easy access to the world’s largest market • Knowledge of global regulations facilitates product supply to international markets • Given Puerto Rico’s tropical geographical location, the local biopharmaceutical industry has developed unique resiliency capabilities and business continuity plans that have been proven in the preparation for and recovery from atmospheric events. • World class STEM education and a qualified, cost-effective workforce • Logical jumping off point for companies to expand into Latin American markets • Competitive incentives for R&D, manufacturing, and exporting pharmaceutical goods matched with an already favorable tax landscape